Form 8-K - Current report:
SEC Accession No. 0001799191-23-000042
Filing Date
2023-09-01
Accepted
2023-09-01 16:00:59
Documents
13
Period of Report
2023-09-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K toi-20230901.htm   iXBRL 8-K 26061
  Complete submission text file 0001799191-23-000042.txt   195693

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT toi-20230901.xsd EX-101.SCH 2306
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT toi-20230901_def.xml EX-101.DEF 15976
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT toi-20230901_lab.xml EX-101.LAB 30813
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT toi-20230901_pre.xml EX-101.PRE 16714
7 EXTRACTED XBRL INSTANCE DOCUMENT toi-20230901_htm.xml XML 4189
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39248 | Film No.: 231232413
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine